MedCity News
APRIL 2, 2023
Inato recently raised $20 million in Series A2 funding for its tech platform, which enables access to inclusive clinical trials. The two-way platform brings exposure to community-based providers who often are overlooked by Big Pharma for clinical trial sites by allowing providers to apply for clinical trials in which they’re interested.
PharmaTech
APRIL 2, 2023
A growing proportion of drugs in the development pipeline nowadays start out life at small biotech companies, rather than big pharma businesses. While this means the biotechs are taking on more risk, they will also reap greater rewards in the event of success. When it comes to choosing your CDMO partner, there is no substitute for a careful selection process to determine the right CDMO to make and manage your precious potential drug.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
APRIL 2, 2023
Narcan, a nasal spray product that reverses the effects of opioid overdose, is now FDA approved for non-prescription use. Other recent FDA approvals include decisions for drugs from Pharming Group, Incyte, and Aurion Biotech.
PharmaTech
APRIL 2, 2023
Alternative approaches to freeze-drying are gaining popularity and will help to overcome some of the challenges associated with conventional lyophilization.
MedCity News
APRIL 2, 2023
By supporting next-generation payment methods that boost security and convenience for consumers, providers can enhance patient satisfaction and loyalty.
PharmaTech
APRIL 2, 2023
As new manufacturing processes and technologies are introduced to meet demand and overcome challenges, understanding also needs to improve to ensure the right balance is achieved.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaTech
APRIL 2, 2023
Despite the advantages intensified processes can offer developers, there are still some obstacles to overcome before broader application of new technologies will be implemented.
PharmaTech
APRIL 2, 2023
A risk assessment should be performed as part of the CAPA process, says Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates.
PharmaTech
APRIL 2, 2023
Considering the differences between small- and large-molecule drug products can help determine analytical testing methods for E&L.
PharmaTech
APRIL 2, 2023
Manufacturers and suppliers join forces to reduce the pharmaceutical industry’s carbon footprint.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
PharmaTech
APRIL 2, 2023
Limitations in production platforms have impeded continuous manufacturing for advanced therapies.
PharmaTech
APRIL 2, 2023
A growing proportion of drugs in the development pipeline nowadays start out life at small biotech companies, rather than big pharma businesses. While this means the biotechs are taking on more risk, they will also reap greater rewards in the event of success. When it comes to choosing your CDMO partner, there is no substitute for a careful selection process to determine the right CDMO to make and manage your precious potential drug.
PharmaTech
APRIL 2, 2023
Review testing requirements for lab balances in the pharmaceutical industry described in the relevant pharmacopoeias and the associated certificates offered by Sartorius.
PharmaTech
APRIL 2, 2023
Unlock the full potential of your pharma/biopharma laboratory with our comprehensive guide on mastering liquid handling techniques for any liquid type.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
PharmaTech
APRIL 2, 2023
Impurities and batch-to-batch variability present the biggest challenges.
PharmaTech
APRIL 2, 2023
Direct-to-consumer drug advertising has developed as a cottage industry which has been used to increase prescriptions immensely.
PharmaTech
APRIL 2, 2023
What can we take away fro Pfifzer's acquisition of Seagen?
PharmaTech
APRIL 2, 2023
Webinar Date/Time: Tue, May 23, 2023 11:00 AM EDT
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
PharmaTech
APRIL 2, 2023
FDA has spurred investment to create and develop 600 therapies.
Expert insights. Personalized for you.
113 
Let's personalize your content